Enyo Pharma
Société
Onglets principaux
À propos de votre organisation / profil
ENYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.
Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
Cette organisation ne comporte pas d'utilisateur pour le moment.
